Pharmafile Logo
Pharmafocus logo
Advanced Search

Zydus Cadila

Showing 10 posts of 10 posts found.

shutterstock_92671375

Cadila and Supernus settle patent dispute over epilepsy generic

March 7, 2017
Manufacturing and Production, Sales and Marketing Cadila, Supernus, Trokendi XR, Zydus Cadila

A patent dispute between Indian pharmaceutical firm Cadila Healthcare and US-based Supernus Pharmaceuticals has been ended with legal calls for …

News

Zydus Cadila scores twin FDA approvals

February 17, 2017
Medical Communications, Sales and Marketing FDA, Zydus Cadila

Indian pharmaceutical firm Zydus Cadila has announced that the US Food and Drug Administration (FDA) has given the go-ahead for …

News
takeda_world

Takeda partners with Zydus to develop chikungunya vaccine

September 20, 2016
Manufacturing and Production, Research and Development Takeda, Zydus Cadila, chikungunya

Zydus Cadila has teamed up with Takeda to develop a vaccine for the chikungunya virus. Zydus Cadila’s group firm Cadila …

News

Pfizer launches legal action to block Xeljanz copies in India

September 9, 2016
Medical Communications, Sales and Marketing Pfizer, Sun Pharma, Xeljanz, Zydus Cadila, rheumatoid arthritis

Pfizer has pre-emptively sued a number of India-based drug companies including Sun Pharma and Zydus Cadila to block any attempts …

News

Zydus nabs FDA approval for type-2 diabetes drug

July 11, 2016
Sales and Marketing Zydus Cadila, nateglinide

Zydus Cadila, a division of Cadila Pharmaceuticals (NSE: CADILAHC), has announced the US Food and Drug Administration (FDA) has approved …

News
Humira image

AbbVie’s Humira meets endpoint in eye disease study

May 6, 2015
Research and Development, Sales and Marketing AbbVie, FDA, Humira, Zydus Cadila, adalimumab, uveitis

In a Phase III trial AbbVie’s anti-inflammatory medicine Humira has been shown to significantly lower the risk of uncontrolled uveitis …

News

Humira biosimilar released in India

December 18, 2014
Research and Development, Sales and Marketing Humira, India, Zydus Cadila, anti-inflammatory, arthritis, bioscience

Indian firm Zydus Cadila has launched the first biosimilar of AbbVie’s anti-inflammatory medicine Humira, the world’s biggest-selling drug. Used as …

News

Bayer and Zydus Cadila sign India deal

February 4, 2011
Sales and Marketing Bayer, India, Indian pharmaceutical industry, Zydus Cadila

Bayer HealthCare and the Indian company Zydus Cadila have signed a deal to form a new joint venture. A new …

News

Zydus Nycomed’s API plant to start production soon

October 4, 2010
Manufacturing and Production API, India, Nycomed, Zydus Cadila

Nycomed has said that construction and validation of an active pharmaceutical ingredient manufacturing unit at its plant in Navi Mumbai, …

News

Abbott strikes emerging markets deal

May 12, 2010
Sales and Marketing Abbott, Zydus Cadila, em

Abbott is seeking to extend its reach into emerging markets with a new collaboration with India-based pharma company Zydus Cadila. …

News

Latest content

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024